RGS4 and epilepsy: It has been demonstrated that RGS4 plays a significant role in various diseases, such as asthma (35), epilepsy (36), and Parkinson’s disease (37), and inhibition of RGS4 with their antagonists can alleviate these diseases, suggesting that RGS proteins might be the potential therapeutic target in those conditions.